Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 39
Filtrer
2.
Zhonghua Yi Xue Za Zhi ; 103(15): 1140-1147, 2023 Apr 18.
Article de Chinois | MEDLINE | ID: mdl-37055232

RÉSUMÉ

Objective: To investigate the clinical application value of the modified Lee grading system (abbreviated as the modified system) in evaluating the degree of intervertebral foraminal stenosis(IFS) in patients with foraminal lumbar disc herniations(FLDH). Methods: MRI data of 83 patients with FLDH-IFS (34 patients in the operation group and 49 patients in the conservative group) in Yantai Affiliated Hospital of Binzhou Medical University and Yantai Yantaishan Hospital from March 2018 to February 2021 were retrospectively collected. There were 43 males and 40 females, ranged from 34 to 82 years old, with an average of (61±10) years. MRI images of selected patients were independently evaluated and recorded by two radiologists in a blind method, using both the Lee grading system (abbreviated as Lee system) and the modified system, respectively and each method was evaluated twice. The difference between the evaluation level of the two systems, and the agreement of observer assessments of the two systems were compared, and the correlation between the evaluation level of the two grading systems and the clinical treatment modalities was analyzed. Results: The percentage of nongrade 3 (grade 0-2) patients with effective conservative treatment according to the two grading systems was 94.6 % (139/147) and 64.2 % (170/265), respectively. The percentage of grade 3 patients requiring surgical treatment according to the two grading systems was 69.2 % (128/185) and 61.2 % (41/67), respectively. There was a statistically significant difference between the evaluation levels of the modified system and the Lee system (Z=-5.16, P=0.001). In the Lee system, the intra-observer observation consistency Kappa values of the two radiologists were 0.735 and 0.542, respectively, which were highly and moderately consistent; and the inter-observer observation consistency Kappa values were 0.426-0.521, which were moderate consistency. In the modified system, the intra-observer consistency Kappa values of the two radiologists were 0.900 and 0.921, respectively, and the consistency was almost completely consistent; and the inter-observer consistency Kappa values were 0.783-0.861, which were highly consistent or almost completely consistent. Lee system and clinical treatment modalities was correlative (rs=0.39,P<0.001), and modified system and clinical treatment modalities was correlative (rs=0.61,P<0.001). Conclusion: According to FLDH-IFS, the modified system can comprehensively and accurately grade, with high reliability and reproducibility. The evaluation level has a more significant correlation with clinical treatment modalities.


Sujet(s)
Déplacement de disque intervertébral , Disque intervertébral , Sténose du canal vertébral , Mâle , Femelle , Humains , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Reproductibilité des résultats , Sténose pathologique , Études rétrospectives , Vertèbres lombales , Imagerie par résonance magnétique/méthodes
3.
Br J Nutr ; 125(3): 251-259, 2021 02 14.
Article de Anglais | MEDLINE | ID: mdl-32718368

RÉSUMÉ

Coated copper sulphate (CCS) could be used as a Cu supplement in cows. To investigate the influences of copper sulphate (CS) and CCS on milk performance, nutrient digestion and rumen fermentation, fifty Holstein dairy cows were arranged in a randomised block design to five groups: control, CS addition (7·5 mg Cu/kg DM from CS) or CCS addition (5, 7·5 and 10 mg Cu/kg DM from CCS, respectively). When comparing Cu source at equal inclusion rates (7·5 mg/kg DM), cows receiving CCS addition had higher yields of fat-corrected milk, milk fat and protein; digestibility of DM, organic matter (OM) and neutral-detergent fibre (NDF); ruminal total volatile fatty acid (VFA) concentration; activities of carboxymethyl cellulase, cellobiase, pectinase and α-amylase; populations of Ruminococcus albus, Ruminococcus flavefaciens and Fibrobacter succinogenes; and liver Cu content than cows receiving CS addition. Increasing CCS addition, DM intake was unchanged, yields of milk, milk fat and protein; feed efficiency; digestibility of DM, OM, NDF and acid-detergent fibre; ruminal total VFA concentration; acetate:propionate ratio; activity of cellulolytic enzyme; populations of total bacteria, protozoa and dominant cellulolytic bacteria; and concentrations of Cu in serum and liver increased linearly, but ruminal propionate percentage, ammonia-N concentration, α-amylase activity and populations of Prevotella ruminicola and Ruminobacter amylophilus decreased linearly. The results indicated that supplement of CS could be substituted with CCS and addition of CCS improved milk performance and nutrient digestion in dairy cows.


Sujet(s)
Aliment pour animaux , Phénomènes physiologiques nutritionnels chez l'animal/effets des médicaments et des substances chimiques , Sulfate de cuivre/administration et posologie , Compléments alimentaires , Animaux , Bovins , Digestion/effets des médicaments et des substances chimiques , Enzymes/effets des médicaments et des substances chimiques , Femelle , Fermentation/effets des médicaments et des substances chimiques , Lactation/effets des médicaments et des substances chimiques , Foie/métabolisme , Microbiote/effets des médicaments et des substances chimiques , Nutriments/métabolisme , Rumen/métabolisme
4.
Zhonghua Zhong Liu Za Zhi ; 42(11): 961-965, 2020 Nov 23.
Article de Chinois | MEDLINE | ID: mdl-33256309

RÉSUMÉ

Objective: To preliminarily explore the treatment effect of nivolumab on Chinese non-small-cell lung cancer (NSCLC) patients with brain metastases, and further enrich the evidences of programmed death-ligand 1 (PD-1) monoclonal antibody in the treatment of NSCLC patients with brain metastases. Methods: The clinical and pathological data of 22 NSCLC patients with brain metastases treated with nivolumab were collected. The electronic imaging data were collected to confirm the treatment effect and time point of disease progression, and the survival data of the patients were obtained through follow-up. Results: Twenty-one patients were evaluated for the intracranial treatment effect. The intracerebral objective response rate (IORR) was 28.6%, the intracranial disease control rate (IDCR) was 47.6%. The median intracranial progression-free-survival (iPFS) of all the 22 patients was 5.2 months. Both the 1-year and 2-year survival rates were 56.7%. Conclusions: The treatment effect of PD-1 monoclonal antibody on NSCLC patients with brain metastases is similar as those without brain metastases.


Sujet(s)
Tumeurs du cerveau , Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Nivolumab , Antinéoplasiques immunologiques/usage thérapeutique , Tumeurs du cerveau/traitement médicamenteux , Tumeurs du cerveau/secondaire , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Humains , Tumeurs du poumon/traitement médicamenteux , Nivolumab/usage thérapeutique , Études rétrospectives , Résultat thérapeutique
5.
Zhonghua Yi Xue Za Zhi ; 100(34): 2682-2688, 2020 Sep 15.
Article de Chinois | MEDLINE | ID: mdl-32921017

RÉSUMÉ

Objective: The aim of present study was to investigate the influence of genetic variation of programmed death-ligand 1 (PD-L1) on the prognosis of patients with non-small cell lung cancer (NSCLC) who received platinum-based adjuvant chemotherapy. Methods: This study was designed as a retrospective analysis, and a total of 278 patients with postoperative NSCLC who received platinum-based adjuvant chemotherapy from January 2012 to December 2018 in the Department of Respiratory Medicine of the First affiliated Hospital of Zhengzhou University were included in this study. Biological specimens of the patients were collected during hospitalization. Recurrence status and adverse reactions were evaluated in the hospital during adjuvant chemotherapy. Survival data of the patients were obtained through telephone follow-up after completing the fixed cycle of adjuvant chemotherapy. DNA extracted from the collected hematological specimens was genotyped for PD-L1 gene polymorphism. Additionally, postoperative cancer tissue specimens from 68 patients were collected for RNA extraction in order to perform the PD-L1 mRNA expression analysis. The univariate analysis of genotypes and prognosis was carried out by Kaplan-Meier survival analysis. Results: Prognostic results indicated that the median disease-free survival (DFS) of the 278 patients with NSCLC was 3.2 years and the median overall survival (OS) was 4.9 years. The prevalence of -1813G>C polymorphism were: GG genotype 173 cases (62.23%), GC genotype 92 cases (33.09%), CC genotype 13 cases (4.68%), the minor allele frequency was 0.21, the distribution of the three genotypes was in accordance with Hardy-Weinberg Equilibrium (P=0.864). In view of the rare frequency of CC genotype, GC and CC genotype were merged in the following analysis. The survival analysis results of the two genotype groups suggested that the median DFS of patients with GG and GC/CC genotype was 2.7 and 4.0 years, which was statistically significant (P=0.013). Furthermore, the median OS of patients with GG and GC/CC was 4.0 and 5.4 years respectively, which was statistically significant as well (P=0.009). However, the safety analysis failed to find the significant association between the polymorphism and adverse events (P>0.05). Interestingly, expression analysis of RNA extracted from cancer tissues specimens indicated that the PD-L1 mRNA expression of the patients with GG genotype were significantly higher than those of the GC/CC genotype (3.67±0.65 vs 2.69±0.78, P<0.001). Conclusion: The prognosis of patients with postoperative non-small cell lung cancer who received platinum-based adjuvant chemotherapy is influenced by -1813G>C polymorphism of PD-L1 gene.


Sujet(s)
Antigène CD274 , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Tumeurs du poumon/traitement médicamenteux , Antigène CD274/génétique , Carcinome pulmonaire non à petites cellules/génétique , Traitement médicamenteux adjuvant , Humains , Tumeurs du poumon/génétique , Récidive tumorale locale , Platine/usage thérapeutique , Pronostic , Études rétrospectives
6.
Br J Nutr ; 123(10): 1109-1116, 2020 05 28.
Article de Anglais | MEDLINE | ID: mdl-31992377

RÉSUMÉ

This study evaluated the effects of rumen-protected folic acid (RPFA) and betaine (BT) on growth performance, nutrient digestion and blood metabolites in bulls. Forty-eight Angus bulls were blocked by body weight and randomly assigned to four treatments in a 2 × 2 factorial design. BT of 0 or 0·6 g/kg DM was supplemented to diet without or with the addition of 6 mg/kg DM of folic acid from RPFA, respectively. Average daily gain increased by 25·2 and 6·29 % for addition of BT without RPFA and with RPFA, respectively. Digestibility and ruminal total volatile fatty acids of neutral-detergent fibre and acid-detergent fibre increased, feed conversion ratio and blood folate decreased with the addition of BT without RPFA, but these parameters were unchanged with BT addition in diet with RPFA. Digestibility of DM, organic matter and crude protein as well as acetate:propionate ratio increased with RPFA or BT addition. Ruminal ammonia-N decreased with RPFA addition. Activity of carboxymethyl cellulase, cellobiase, xylanase, pectinase and protease as well as population of total bacteria, protozoa, Fibrobacter succinogenes and Ruminobacter amylophilus increased with RPFA or BT addition. Laccase activity and total fungi, Ruminococcus flavefaciens and Prevotella ruminicola population increased with RPFA addition, whereas Ruminococcus albus population increased with BT addition. Blood glucose, total protein, albumin, growth hormone and insulin-like growth factor-1 increased with RPFA addition. Addition of RPFA or BT decreased blood homocysteine. The results indicated that addition of BT stimulated growth and nutrient digestion in bulls only when RPFA was not supplemented.


Sujet(s)
Bétaïne/administration et posologie , Bovins/croissance et développement , Compléments alimentaires , Digestion/effets des médicaments et des substances chimiques , Acide folique/administration et posologie , Rumen/métabolisme , Aliment pour animaux/analyse , Animaux , Acides gras volatils/métabolisme , Fermentation/effets des médicaments et des substances chimiques , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Mâle
7.
Zhonghua Zhong Liu Za Zhi ; 41(10): 783-791, 2019 Oct 23.
Article de Chinois | MEDLINE | ID: mdl-31648503

RÉSUMÉ

Objective: To investigate the clinical effects of first generation epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) compared with platinum-based chemotherapy as first-line therapy in advanced lung adenocarcinoma patients with uncommon EGFR mutations. Methods: Clinical data of 4 276 patients diagnosed as advanced lung adenocarcinoma (ⅢB/Ⅳ) underwent EGFR gene detection at the Affiliated Cancer Hospital of Zhengzhou University from January 2012 to February 2018 were collected and 99 cases with uncommon EGFR mutations were selected. The clinical pathological features, treatment outcomes, treatment options and prognosis after first-line treatment of the 99 cases were analysed and compared with other patients with common EGFR mutations. Results: The objective response rates of patients with uncommon EGFR mutations receiving EGFR-TKIs or platinum-based chemotherapy were 33.0% and 27.1%, respectively. The disease control rates were 76.5% and 87.5%, respectively. The progression-free survival (PFS) of patients treated with EGFR-TKIs was 7.2 months, significantly superior than 4.9 months of patients receiving chemotherapy (P=0.009). The overall survival of patients treated with EGFR-TKIs was 14.3 months, significantly worse than 20.7 months of patients receiving chemotherapy (P=0.034). Multivariate analysis showed that distant metastases (P=0.001) and smoking history (P=0.013) were independent prognostic factors for OS of lung adenocarcinoma patients with EGFR uncommon mutations. Conclusions: Compared with chemotherapy, the usage of first generation of EGFR-TKIs as first-line therapy can improve the short-term efficacy of advanced lung adenocarcinoma patients with EGFR uncommon mutations. However, platinum-based chemotherapy shows a longer overall survival.


Sujet(s)
Adénocarcinome pulmonaire/traitement médicamenteux , Récepteurs ErbB/usage thérapeutique , Gènes erbB-1/effets des médicaments et des substances chimiques , Gènes erbB-1/génétique , Tumeurs du poumon/traitement médicamenteux , Inhibiteurs de protéines kinases/usage thérapeutique , Adénocarcinome pulmonaire/anatomopathologie , Humains , Tumeurs du poumon/anatomopathologie , Mutation , Résultat thérapeutique
8.
Anim Genet ; 50(6): 740-743, 2019 Dec.
Article de Anglais | MEDLINE | ID: mdl-31475374

RÉSUMÉ

The yattle (dzo) is an interspecific hybrid of the taurine cattle (Bos taurus) and the domestic yak (Bos grunniens). F1 hybrid yattle bulls are sterile due to spermatogenic arrest and have misregulation of spermatogenesis genes in the testes. However, the expression pattern of Y chromosome-linked genes in cattle, yaks and yattle testes is still unknown. In this study, we analyzed the mRNA expression pattern of 10 genes known to be present as single copies in the X-degenerate region of the bovine male-specific region of the Y chromosome. Using male-specific primers and reverse transcription quantitative PCR, the ubiquitously transcribed tetratricopeptide repeat gene, Y-linked (UTY), oral-facial-digital syndrome 1, Y-linked (OFD1Y) and ubiquitin specific peptidase 9, Y-linked (USP9Y) genes were ubiquitously expressed and significantly more highly expressed in yattle than in cattle and yaks testes (P < 0.001). RNA binding motif protein, Y-linked (RBMY) had testes-specific expression, and eukaryotic translation initiation factor 1A, Y-linked (EIF1AY) was expressed mainly in testis, whereas yattle and cattle did not show significant differences with respect to the expression of RBMY and EIF1AY. Thus, based on the model of yattle bull sterility, the high expression of UTY, OFD1Y and USP9Y may be associated with yattle infertility.


Sujet(s)
Bovins/génétique , Régulation de l'expression des gènes , Testicule/métabolisme , Animaux , Bovins/classification , Bovins/physiologie , Femelle , Hybridation génétique , Infertilité masculine/médecine vétérinaire , Mâle , Spermatogenèse , Transcriptome , Chromosome Y
9.
Eur Rev Med Pharmacol Sci ; 23(10): 4313-4320, 2019 May.
Article de Anglais | MEDLINE | ID: mdl-31173304

RÉSUMÉ

OBJECTIVE: Exercise-based intervention promises to be more effective in a structured framework for individuals with autism spectrum disorders (ASD). The aim of this study was to observe changes in behavior of individuals with ASD by investigating their physical status after the structured exercise-based intervention. PATIENTS AND METHODS: The exercise intervention integrated an 8-week exercise program that included aerobic, resistive, and neuromuscular exercises. Body composition and the Autism Treatment Evaluation Checklist (ATEC) were evaluated to assess changes after the exercise-based intervention. RESULTS: After the exercise intervention, the fat mass of individuals with ASD were significantly reduced, and their behavior improved markedly. CONCLUSIONS: This pilot study demonstrated that individuals with ASD require long-term, structured exercise-based intervention, and that such exercise-based intervention is effective for improving their health.


Sujet(s)
Trouble du spectre autistique/complications , Trouble du spectre autistique/thérapie , Traitement par les exercices physiques/méthodes , Adolescent , Trouble du spectre autistique/psychologie , Conscience immédiate , Composition corporelle , Répartition du tissu adipeux , Enfant , Communication , Femelle , Humains , Mâle , Tests neuropsychologiques , Projets pilotes , Entraînement en résistance , Comportement social , Résultat thérapeutique
10.
Eur Rev Med Pharmacol Sci ; 23(9): 3779-3789, 2019 May.
Article de Anglais | MEDLINE | ID: mdl-31115004

RÉSUMÉ

OBJECTIVE: MicroRNAs (miRNAs) are involved in the tumorigenesis and progression of multiple tumor types and function as either tumor suppressor genes or oncogenes. This study was designed to investigate the functional behaviors and regulatory mechanisms of miR-105 in the progression of gastric carcinoma. PATIENTS AND METHODS: 24 pairs of patients with gastric carcinoma were enrolled in this study. The levels of miR-105 in gastric carcinoma tissues and cells were determined using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay. The biological functions of miR-105 in gastric carcinoma cell were detected by colony formation, transwell invasion and wound-healing assay. Luciferase activity assay and immunoblotting assay were applied to validate the direct target of miR-105. The expression of SRY-Box 9 (SOX9) was detected using immunofluorescence staining assay. Furthermore, the role of miR-105 on the growth of gastric carcinoma cell was examined in the established xenograft model. The role of miR-105 in the metastasis of gastric carcinoma cell in vivo, an experimental metastasis assay was performed. RESULTS: Herein, we proved that miR-105 was down-regulated in gastric carcinoma specimens as well as gastric cancer cells. Up-regulation of miR-105 suppressed the colony formation and aggressiveness traits of gastric carcinoma cell lines BGC823 and SGC7901 in vitro. Furthermore, over-expression of miR-105 inhibited the tumor growth as well as lung metastasis of gastric carcinoma cell in vivo. Further investigation identified SOX9 was the target gene of miR-105 in gastric cancer and its expression was negatively associated with the expression of miR-105 in gastric carcinoma tissues. Finally, overexpression of SOX9 partially reversed the influence of miR-105 on the growth and aggressiveness of gastric carcinoma cell. CONCLUSIONS: These results revealed the crucial role of miR-105 in the progression and metastasis of gastric carcinoma, which indicated the potential application of miR-105 in the treatment of gastric carcinoma.


Sujet(s)
microARN/métabolisme , Facteur de transcription SOX-9/métabolisme , Tumeurs de l'estomac/anatomopathologie , Régions 3' non traduites , Animaux , Sites de fixation , Mouvement cellulaire , Prolifération cellulaire , Humains , Souris , Souris de lignée BALB C , microARN/antagonistes et inhibiteurs , microARN/génétique , Mutagenèse , Interférence par ARN , Petit ARN interférent/métabolisme , Facteur de transcription SOX-9/antagonistes et inhibiteurs , Facteur de transcription SOX-9/génétique , Tumeurs de l'estomac/génétique , Régulation positive , Tests d'activité antitumorale sur modèle de xénogreffe
11.
Article de Chinois | MEDLINE | ID: mdl-30419671

RÉSUMÉ

Objective: To investigate the changes of brain gray matter volume in patients with occupational noise-induced hearing loss by voxel based morphometry (VBM) . Methods: 16 age-and education-matched healthy controls and 42 patients with occupational noise induced hearing loss, including 27 in mild group and 15 in severe group, received MRI 3D-FSPGR sequence T1WI sagittal scan, and then underwent VBM of brain gray matter volume data analysis. Results: The brain gray matter volume of the left occipitotemporal lateral gyrus, the anterior cingulate gyrus, the bilateral angular gyrus, the precuneus and the near midline area of cerebellum differed between experimental group and control group (P<0.01) . Conclusion: The volume of gray matter in specific brain areas of patients with occupational noise-induced hearing loss was changed, and the effect of noise on brain structure was revealed from the perspective of imaging.


Sujet(s)
Substance grise/imagerie diagnostique , Surdité due au bruit/imagerie diagnostique , Maladies professionnelles/imagerie diagnostique , Études cas-témoins , Humains , Imagerie par résonance magnétique/méthodes
12.
Eur Rev Med Pharmacol Sci ; 21(3): 569-575, 2017 02.
Article de Anglais | MEDLINE | ID: mdl-28239810

RÉSUMÉ

OBJECTIVE: The purpose of this study is to compare the effectiveness and safety of thoracoscopic surgery and traditional median sternotomy. PATIENTS AND METHODS: 64 patients with atrial myxoma and 114 patients with atrial septal defect were collected from Mar 2012 to Aug 2015. 40 atrial myxoma and 77 atrial septal defect (ASD) patients underwent totally thoracoscopic surgery technique, while 24 atrial myxoma and 37 ASD patients underwent traditional median sternotomy. The baseline characteristics and perioperative data were recorded and analyzed from all cases. Follow-up data were obtained from outpatient clinics. RESULTS: All patients had successful resections or repairs. Compared with the traditional median sternotomy, the patients with atrial myxoma who underwent thoracoscopic surgery had longer operation time (208.08 ± 23.98 vs. 170.00 ± 16.58 min) while shorter intensive care unit (ICU) stay time (17.67 ± 4.95 vs. 49.88 ± 3.21 h), less blood drainage (127.87 ± 48.84 vs. 275.00 ± 59.01 ml) and shorter hospitalization days (9.97 ± 3.54 vs. 15.13 ± 1.06 days). For patients underwent ASD repair, longer operation time (232.92 ± 61.02 vs. 183.40 ± 54.63 min), shorter mechanical assistant ventilation time (4.82 ± 2.10 vs. 6.02 ± 2.50 h) and shorter ICU stay time (18.54 ± 5.80 vs. 39.68 ± 18.44 h) were detected in the thoracoscopic surgery group. There was no postoperative embolism events or death in all participated patients. Neither residual shunt nor atrioventricular blocks were detected in all ASD patients. CONCLUSIONS: Totally thoracoscopic surgery for atrial myxomas and atrial septal defect repair is more effective and safer. It provides another option to treat the patients with atrial myxoma and atrial septal defect.


Sujet(s)
Communications interauriculaires/chirurgie , Myxome/chirurgie , Thoracoscopie , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Durée opératoire , Sternotomie , Résultat thérapeutique , Jeune adulte
14.
J Anim Sci ; 94(4): 1398-407, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-27135999

RÉSUMÉ

Crossbreeding between cattle () and yak () exhibits significant hybrid advantages in milk yield and meat production. By contrast, cattle-yak F hybrid bulls are sterile. Copy number variations (CNV) of multicopy gene families in male-specific regions of the mammalian Y chromosome (MSY) affect human and animal fertility. The present study investigated CNV of (), (), (), and () in 5 yak breed bulls ( = 63), cattle-yak F ( = 22) and F ( = 2) hybrid bulls, and Chinese Yellow (CY) cattle bulls ( = 10) by quantitative real-time PCR. showed restricted amplification in yak bulls in that the average geometric mean copy number (CN) was estimated to be 4 copies. The most compelling finding is that there is a tremendous expansion of CN in F hybrids (385 copies; 95% confidence interval [CI] = 351-421) and F hybrids (356 copies) compared with the male parent breed CY cattle (142 copies; 95% CI = 95-211). Copy numbers of and were also extensively expanded on the Y chromosome in yak and CY cattle bulls. The geometric mean CN of and were estimated to be 123 (95% CI = 114-132) and 250 copies (95% CI = 233-268) in yak bulls and 71 (95% CI = 61-82) and 133 (95% CI = 107-164) copies in CY cattle, respectively. Yak and CY cattle have 2 copies of the gene on the Y chromosome. Similarly to gene, the F and F hybrid bulls have higher CN of , , and than CY cattle ( < 0.01). These results indicated that the MSY of yak and cattle-yak crossbred hybrids was fundamentally different from cattle MSY in the context of genomic organization. Based on the model of cattle-yak F and F hybrid bull sterility, the CNV of may serve as a potential risk factor for crossbred bull ( × ) infertility. To our knowledge, this is the first study to examine differences in multicopy genes in MSY between yak and cattle-yak bulls.


Sujet(s)
Sélection , Bovins/génétique , Protéines du cycle cellulaire/métabolisme , Variations de nombre de copies de segment d'ADN , Fécondité/génétique , Animaux , Protéines du cycle cellulaire/génétique , Génome , Hybridation génétique , Mâle , Réaction de polymérisation en chaine en temps réel , Chromosome Y
15.
Nutr Metab Cardiovasc Dis ; 25(2): 218-23, 2015 Feb.
Article de Anglais | MEDLINE | ID: mdl-25456154

RÉSUMÉ

BACKGROUND AND AIMS: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. METHODS AND RESULTS: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4 ± 42.1 cm/s for men, 95.8 ± 36.7 cm/s for women) than in the subjects without NAFLD (70.3 ± 56.5 cm/s for men, 55.4 ± 42.2 cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, ß = 0.843; P < 0.001; for female, ß = 0.575; P < 0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. CONCLUSIONS: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness.


Sujet(s)
Maladies cardiovasculaires/anatomopathologie , Stéatose hépatique non alcoolique/anatomopathologie , Rigidité vasculaire , Index de pression systolique cheville-bras , Vitesse du flux sanguin , Indice de masse corporelle , Maladies cardiovasculaires/complications , Évolution de la maladie , Femelle , Études de suivi , Humains , Mâle , Syndrome métabolique X/complications , Syndrome métabolique X/anatomopathologie , Adulte d'âge moyen , Stéatose hépatique non alcoolique/complications , Études prospectives , Écoulement pulsatoire , Analyse de l'onde de pouls , Facteurs de risque
16.
Vet J ; 202(1): 89-93, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-25023088

RÉSUMÉ

Psoriasin (S100A7) is a member of the S100 protein family of calcium-binding proteins and plays a crucial role in local host defenses. The present study aimed to identify the expression of S100A7 in the goat mammary gland and in milk. The goat S100A7 coding DNA sequence was identified using direct sequencing. An S100A7 antibody was raised in rabbits by immunization with a synthetic S100A7 peptide consisting of 13 amino acids. Messenger RNA expression and protein localization in different regions of a healthy mammary gland were detected by reverse transcription-polymerase chain reaction and immunohistochemistry. Changes in the concentration of S100A7 in the milk after an intramammary infusion of Escherichia coli lipopolysaccharide (LPS) were examined by an enzyme immunoassay. The goat S100A7 peptide had 98% and 86% sequence similarity to that of sheep and bovines, respectively. The S100A7 mRNA expression was higher in the teat and udder skin than in the cistern and parenchyma of the mammary gland. Immunoreactive S100A7 was localized in the epithelial cells of the alveolus and gland cistern, and stratified squamous epithelium of the teat. Psoriasin as a secreted protein was detectable in healthy milk, and an intramammary LPS infusion increased the concentration of S100A7 in the milk. The results suggest that S100A7 is produced in the epithelial cells of the mammary gland and is secreted into the milk.


Sujet(s)
Capra/métabolisme , Lipopolysaccharides/toxicité , Glandes mammaires animales/effets des médicaments et des substances chimiques , Lait/composition chimique , ARN messager/métabolisme , Protéines S100/métabolisme , Séquence d'acides aminés , Animaux , Femelle , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Lipopolysaccharides/administration et posologie , Glandes mammaires animales/métabolisme , Données de séquences moléculaires , ARN messager/génétique , Protéines S100/composition chimique , Protéines S100/génétique
17.
J Anim Sci ; 91(9): 4051-9, 2013 Sep.
Article de Anglais | MEDLINE | ID: mdl-23893974

RÉSUMÉ

Dectin-1 plays a critical role in the pathogenesis of intestinal inflammation by recognizing the pathogenic agents and mediating cytokine responses. The objective of this study was to establish the association between dectin-1 polymorphisms and susceptibility to nonspecific digestive disorders (NSDD) and cytokine expression in rabbits. A total of 7 coding SNP were detected in dectin-1 gene. The genetic association between SNP (ss707197675A > G) and susceptibility to NSDD was evaluated using a case-control study (178 cases and 174 controls). The results revealed that the A allele was associated with an increased risk of developing NSDD in rabbits. The AA genotype significantly increased the genetic susceptibility to NSDD with odds ratio of 4.76 (95% confidence interval, 1.92-12.50, P = 0.0002) compared with GG and GA genotypes. We also experimentally induced NSDD in another independent growing rabbit population by feeding a low-fiber diet and subsequently investigated the cytokine mRNA expression. Among the 4 studied cytokines, the expression of interferon-γ, IL-17F, and IL-22 were increased 2.8 to 6.0-fold in AA genotype compared with GG genotype (P < 0.01). The greater IL-17F and IL-22 mRNA expressions indicated a positive correlation with severe intestinal inflammation (P < 0.05). The decreased expression of IL-10 was associated with severe intestinal inflammation (P = 0.006), but IL-10 expression was not influenced by dectin-1 genotype. In conclusion, polymorphism ss707197675 of dectin-1 is related with susceptibility to NSDD and increased expression of proinflammatory cytokines, and dectin-1 could be an important candidate gene associated with NSDD in rabbits.


Sujet(s)
Cytokines/génétique , Maladies de l'appareil digestif/médecine vétérinaire , Lectines de type C/génétique , Polymorphisme de nucléotide simple , Lapins , Séquence d'acides aminés , Animaux , Études cas-témoins , Cytokines/métabolisme , Maladies de l'appareil digestif/génétique , Études d'associations génétiques/médecine vétérinaire , Prédisposition génétique à une maladie , Lectines de type C/métabolisme , Odds ratio , Réaction de polymérisation en chaîne/médecine vétérinaire , Lapins/génétique , Lapins/métabolisme , Répartition aléatoire , Alignement de séquences/médecine vétérinaire
18.
Clin Exp Dermatol ; 37(6): 672-6, 2012 Aug.
Article de Anglais | MEDLINE | ID: mdl-22680787

RÉSUMÉ

Porokeratosis is a rare disorder of epidermal keratinization that is characterized by the presence of a border called the cornoid lamella. Disseminated superficial porokeratosis (DSP) is a subtype of porokeratosis, which is inherited as an autosomal trait. The first locus for DSP was localized to chromosome 18p11.3, but no causative gene has yet been identified. In this study, we recruited and analysed a large six-generation Chinese family with autosomal dominant DSP. The genome-wide screening identified a maximum two-point LOD score of 3.06 at θ = 0.00 with the microsatellite marker D12S78. Fine mapping and haplotype analysis defined a critical region of 38 Mb between D12S326 and D12S79 on chromosome 12q21.2-24.21, which is a probable second locus identified for DSP (DSP2). We sequenced 50 candidate genes in this region, but no causative mutation was found. This study provides a map location for isolation of a gene causing DSP.


Sujet(s)
Chromosomes humains de la paire 12/génétique , Porokératose/génétique , Adolescent , Adulte , Asiatiques/génétique , Enfant , Cartographie chromosomique , Femelle , Liaison génétique , Marqueurs génétiques , Humains , Mâle , Répétitions microsatellites/génétique , Jeune adulte
19.
Neurochem Res ; 37(2): 428-35, 2012 Feb.
Article de Anglais | MEDLINE | ID: mdl-21996785

RÉSUMÉ

Dopamine regulates pain perception in some areas of the central nervous system. Previously, we have confirmed that dopamine potentiated the electric activities of the evoked discharges of pain-excited neurons (PENs) and inhibited those of pain-inhibited neurons (PINs) in the parafascicular nucleus (Pfn) of normal rats. The mechanism of action of dopamine on pain-related neurons in the Pfn of morphine-dependent rat is still unknown. The present study aimed to determine the effects of dopamine and its receptor antagonist droperidol on the pain-evoked responses of the PEN and PIN in the Pfn of morphine-dependent rats, and to compare the effects between the morphine-dependent rat and the normal rat. The trains of electric impulses applied to the sciatic nerve were used as noxious stimulation. The discharges of PEN or PIN in the Pfn were recorded by using a glass microelectrode. The results showed that intra-Pfn microinjection of dopamine decreased the frequency of noxious stimulation-induced discharges of PEN and increased the frequency of PIN. The intra-Pfn administration of droperidol produced an opposite effect. These results demonstrated that dopamine is involved in nociceptive modulation in the morphine-dependent rat, the responses to noxious stimulation between normal rat and morphine-dependent rat are completely opposite. The effect of dopamine is through the dopamine D(2) receptor of PENs and PINs in Pfn. The results suggest that the dopamine system of the Pfn may become a therapeutic target for analgesia and the treatment of morphine dependence.


Sujet(s)
Dopamine/physiologie , Noyaux intralaminaires du thalamus/effets des médicaments et des substances chimiques , Morphine/pharmacologie , Nociception/physiologie , Troubles liés aux opiacés/physiopathologie , Animaux , Potentiels évoqués , Femelle , Noyaux intralaminaires du thalamus/métabolisme , Noyaux intralaminaires du thalamus/physiologie , Mâle , Rats , Rat Sprague-Dawley
20.
J Neural Transm (Vienna) ; 118(4): 555-61, 2011 Apr.
Article de Anglais | MEDLINE | ID: mdl-21246223

RÉSUMÉ

Acetylcholine (ACh) regulates pain perception in the central nervous system. However, the mechanism of action of ACh on pain-related neurons in the hippocampal CA3 is not clear. The present study aimed to determine the effect of ACh, muscarinic ACh receptors (mAChRs) agonist pilocarpine and mAChRs antagonist atropine on the pain-evoked responses of pain-excited neuron (PEN) and pain-inhibited neuron (PIN) in the hippocampal CA3 of normal rats. The trains of electric impulses applied to the sciatic nerve were used as noxious stimulation. The electric activities of PEN or PIN in the hippocampal CA3 were recorded by using a glass microelectrode. Our results showed that, in the hippocampal CA3, the intra-CA3 microinjection of ACh (2 µg/1 µl) or pilocarpine (2 µg/1 µl) decreased the discharge frequency and prolonged firing latency of PEN, and increased the discharge frequency and shortened firing inhibitory duration (ID) of PIN, i.e. exhibiting the analgesic effect of ACh or pilocarpine. The intra-CA3 administration of atropine (0.5 µg/1 µl) produced an opposite effect. On the basis of the above-mentioned findings, we can deduce that ACh and mAChRs in the hippocampal CA3 are involved in the modulation of nociceptive response by regulating the electric activities of PEN and PIN.


Sujet(s)
Acétylcholine/pharmacologie , Potentiels d'action/effets des médicaments et des substances chimiques , Région CA3 de l'hippocampe/effets des médicaments et des substances chimiques , Région CA3 de l'hippocampe/physiopathologie , Douleur/traitement médicamenteux , Douleur/physiopathologie , Acétylcholine/physiologie , Potentiels d'action/physiologie , Animaux , Agonistes cholinergiques/pharmacologie , Stimulation électrique/effets indésirables , Stimulation électrique/méthodes , Femelle , Agonistes muscariniques/pharmacologie , Antagonistes muscariniques/pharmacologie , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Rats , Rat Wistar
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...